Target type: biologicalprocess
A metabolic process that results in the oxidation of reduced nicotinamide adenine dinucleotide, NADH, to the oxidized form, NAD+. [GOC:ai]
NADH oxidation is a fundamental process in cellular respiration, where the reduced form of nicotinamide adenine dinucleotide (NADH) is oxidized to NAD+, releasing electrons that fuel the electron transport chain. This process occurs within the mitochondria, specifically in the inner mitochondrial membrane. The oxidation of NADH is catalyzed by the enzyme NADH dehydrogenase, also known as Complex I of the electron transport chain. This complex acts as a proton pump, translocating protons from the mitochondrial matrix to the intermembrane space, creating a proton gradient. The electrons from NADH are passed along a series of electron carriers within Complex I, including flavin mononucleotide (FMN) and iron-sulfur clusters. The final electron acceptor in the electron transport chain is molecular oxygen (O2), which is reduced to water (H2O). The energy released during electron transfer is used to pump protons across the mitochondrial membrane, generating the proton gradient that drives ATP synthesis via ATP synthase. NADH oxidation is tightly coupled to the reduction of oxygen, ensuring that the electron transport chain remains functional. This process is essential for energy production in all aerobic organisms, providing the majority of ATP required for cellular functions. The efficiency of NADH oxidation is crucial for cellular metabolism, as it directly influences the production of ATP, the primary energy currency of cells.'
"
Protein | Definition | Taxonomy |
---|---|---|
NAD | An NAD(P)H dehydrogenase [quinone] 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P15559] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
4'-bromoflavone | 4'-bromoflavone: structure in first source | ||
beta-naphthoflavone | beta-naphthoflavone : An extended flavonoid resulting from the formal fusion of a benzene ring with the f side of flavone. beta-Naphthoflavone: A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. (Proc Soc Exp Biol Med 1994 Dec:207(3):302-308) | extended flavonoid; naphtho-gamma-pyrone; organic heterotricyclic compound | aryl hydrocarbon receptor agonist |
beta-lapachone | beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities. beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
vitamin k 3 | Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. | 1,4-naphthoquinones; vitamin K | angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical |
sulforaphane | sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen. sulforaphane: from Cardaria draba L. | isothiocyanate; sulfoxide | antineoplastic agent; antioxidant; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite |
c 1303 | C 1303: DNa-binding drug; structure given indicates that the cpd should be the dimethylamino cpd, but it is named as the diethylamino cpd | ||
nsc 366140 | NSC 366140: a 9-methoxypyrazoloacridine; structure given in first source | ||
5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione | 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione: structure in first source | ||
bisantrene | |||
4,3',5'-tri-o-methylpiceatannol | |||
memoquin | memoquin: structure in first source | ||
dicumarol | Dicumarol: An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. | hydroxycoumarin | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; Hsp90 inhibitor; vitamin K antagonist |
ethyl biscoumacetate | Ethyl Biscoumacetate: A coumarin that is used as an anticoagulant. It has actions similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p226) | hydroxycoumarin | |
nsc 158393 | NSC 158393: structure given in first source |